Journal of Clinical Psychopharmacology

Developing a Clozapine Titration Monitoring Algorithm: Integration of Evidence and Clinical Experience at a University Hospital dlvr.it/TLynZ4

New study of over 120,000 #clozapine therapeutic drug monitoring samples finds #smokers may need lower #plasma levels than nonsmokers for treatment-resistant #schizophrenia. Adverse drug reactions appear earlier in nonsmokers, particularly in women. 🔗 journals.lww.com/psychopharmaco…

Developing a Clozapine Titration Monitoring Algorithm: Integration of Evidence and Clinical Experience at a University Hospital dlvr.it/TLYCPJ

Use of Clozapine in Pregnancy: A Retrospective Study From North India dlvr.it/TLYBGH

A newly published case report in JCP presents what may be the first documented instance of a #manic episode potentially triggered by #primidone in a patient with essential tremor and a history of depression. 🔗 journals.lww.com/psychopharmaco…

Rare impulse control problems associated with #aripiprazole may be overlooked. A new case series highlights two patients with prior substance use disorders who developed compulsive substance use while on aripiprazole, which resolved after discontinuation. journals.lww.com/psychopharmaco…

How Does Drug Company Marketing Affect Physician Prescribing? dlvr.it/TLwhHR

In a new study from Mayo Clinic, EHR-derived outcomes (like antidepressant non-refill) were tested as proxies for treatment response. Findings support non-refill as a scalable, real-world measure of antidepressant tolerability. Read more in our new issue: journals.lww.com/psychopharmaco…

Childhood Bruxism Associated With Sertraline Dose Increase: A Case Report dlvr.it/TLvg2Q

Question: Is it safe for people with cancer and other serious conditions to combine cannabidiol with melatonin when neither has worked well enough for insomnia when used alone? dlvr.it/TLrDJ4

Can a patient's family history of medication response help guide treatment for mood disorders? Although this approach is widely used, a new systematic review finds that the supporting evidence is limited. 📘 Article: journals.lww.com/psychopharmaco… 🎧 Podcast: jcpjournal.libsyn.com/a-systematic-r…

Are doctors being subtly influenced by the pharmaceutical industry — even through e-prescribing alerts? Dr. Jeffrey Mattes’ guest editorial and podcast expose how marketing shapes clinical decisions. 🎧 Podcast: jcpjournal.libsyn.com/how-does-drug-… 📰 Editorial: journals.lww.com/psychopharmaco…

Our July/August 2025 issue (Volume 45, issue 4) is now available online:  journals.lww.com/psychopharmaco… Brief synopsis of the new issue from the Journal of Clinical Psychopharmacology Editor-in-Chief is below.

How Does Drug Company Marketing Affect Physician Prescribing? dlvr.it/TLYCGR

Childhood Bruxism Associated With Sertraline Dose Increase: A Case Report dlvr.it/TLYC7Z

Question: Is it safe for people with cancer and other serious conditions to combine cannabidiol with melatonin when neither has worked well enough for insomnia when used alone? dlvr.it/TLYC1q

Semaglutide-Mediated Lithium Toxicity dlvr.it/TLYBtz

Lumateperone for Mixed Features in MDD and Bipolar Depression: Advancing Treatment or Raising New Questions dlvr.it/TLYBhs

Reply to Letter From Surekha et al: “Lumateperone for Mixed Features in MDD and Bipolar Depression: Advancing Treatment or Raising New Questions” dlvr.it/TLYBWt

The Potential Benefits of Chromium and Selenium Supplementation Across Psychiatric Disorders and Symptoms dlvr.it/TLYBQ9